
    
      OBJECTIVES:

        -  To investigate the efficacy and safety of paclitaxel and cisplatin as first-line
           chemotherapy in patients with stage IC-IV ovarian epithelial cancer.

      OUTLINE: This is a multicenter study.

      Patients receive paclitaxel IV and cisplatin IV once every 2 weeks. Treatment repeats every 2
      weeks for 9 courses in the absence of disease progression or unacceptable toxicity.
    
  